DK3894424T3 - Mesylatsalt af en amino-lupan-forbindelse med HIV-modningshæmmende aktivitet - Google Patents

Mesylatsalt af en amino-lupan-forbindelse med HIV-modningshæmmende aktivitet Download PDF

Info

Publication number
DK3894424T3
DK3894424T3 DK19823817.2T DK19823817T DK3894424T3 DK 3894424 T3 DK3894424 T3 DK 3894424T3 DK 19823817 T DK19823817 T DK 19823817T DK 3894424 T3 DK3894424 T3 DK 3894424T3
Authority
DK
Denmark
Prior art keywords
lupane
amino
compound
inhibitory activity
mesylate salt
Prior art date
Application number
DK19823817.2T
Other languages
English (en)
Inventor
Amy Woods
Original Assignee
Viiv Healthcare Uk No 4 Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Viiv Healthcare Uk No 4 Ltd filed Critical Viiv Healthcare Uk No 4 Ltd
Application granted granted Critical
Publication of DK3894424T3 publication Critical patent/DK3894424T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J63/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008Expansion of ring D by one atom, e.g. D homo steroids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • AIDS & HIV (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK19823817.2T 2018-12-10 2019-12-09 Mesylatsalt af en amino-lupan-forbindelse med HIV-modningshæmmende aktivitet DK3894424T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862777432P 2018-12-10 2018-12-10
US201962874557P 2019-07-16 2019-07-16
PCT/IB2019/060564 WO2020121161A1 (en) 2018-12-10 2019-12-09 Mesylate salt of an amino-lupane compound with hiv maturation inhibitory activity

Publications (1)

Publication Number Publication Date
DK3894424T3 true DK3894424T3 (da) 2023-03-06

Family

ID=68944386

Family Applications (1)

Application Number Title Priority Date Filing Date
DK19823817.2T DK3894424T3 (da) 2018-12-10 2019-12-09 Mesylatsalt af en amino-lupan-forbindelse med HIV-modningshæmmende aktivitet

Country Status (14)

Country Link
US (1) US20220024970A1 (da)
EP (1) EP3894424B1 (da)
JP (1) JP2022510475A (da)
DK (1) DK3894424T3 (da)
ES (1) ES2938486T3 (da)
FI (1) FI3894424T3 (da)
HR (1) HRP20230208T1 (da)
HU (1) HUE061184T2 (da)
LT (1) LT3894424T (da)
PL (1) PL3894424T3 (da)
PT (1) PT3894424T (da)
RS (1) RS64113B1 (da)
SI (1) SI3894424T1 (da)
WO (1) WO2020121161A1 (da)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014184553A1 (en) * 2013-05-15 2014-11-20 Cipla Limited Pharmaceutical antiretroviral compositions
PL3129392T3 (pl) * 2014-04-11 2021-04-06 VIIV Healthcare UK(No.4) Limited Triterpenoidy o aktywności hamującej dojrzewanie hiv, podstawione w pozycji 3 niearomatycznym pierścieniem zawierającym podstawnik fluorowcoalkilowy

Also Published As

Publication number Publication date
HRP20230208T1 (hr) 2023-04-14
FI3894424T3 (fi) 2023-04-25
HUE061184T2 (hu) 2023-05-28
PT3894424T (pt) 2023-02-28
PL3894424T3 (pl) 2023-05-02
RS64113B1 (sr) 2023-04-28
LT3894424T (lt) 2023-03-10
ES2938486T3 (es) 2023-04-11
JP2022510475A (ja) 2022-01-26
WO2020121161A1 (en) 2020-06-18
EP3894424B1 (en) 2023-01-25
US20220024970A1 (en) 2022-01-27
EP3894424A1 (en) 2021-10-20
SI3894424T1 (sl) 2023-04-28

Similar Documents

Publication Publication Date Title
DK3866587T3 (da) Overvågning af husdyr
DK3377059T3 (da) Hæmmere af cxcr2
DK3554240T3 (da) Kombinationer af aktive forbindelser
DK3798222T3 (da) Krystallinsk form af den frie base af lorlatinib
MA47596A (fr) Formes cristallines du dérivé 4-pyrimidinesulfamide aprocitentan
DK3457851T3 (da) Derivater af sobetirom
ES2972481T3 (es) Compuestos herbicidas
DK3833662T3 (da) Inhibitorer af protein-protein-interaktionen mellem KEAP-1-NRF2-
DK3692039T3 (da) Enantiomerer af substituerede thiazoler som antivirale forbindelser
DK3649781T3 (da) Forbedring af tvungen grænseopdeling
DK3328395T3 (da) Ny brug af dextransulfat
DK3508793T3 (da) Komfurbeskyttelse under anvendelse af bredt synsfelt
DK3390412T3 (da) Vandopløselige derivater af 3,5-diphenyl-diazolforbindelser
DK3185587T3 (da) Høreanordning med undertrykkelse af lydimpulser
DK3472314T3 (da) Fremstilling af faktor-xa-derivater
DK3717503T3 (da) Albumin-bindende prodrugs af auristatin E derivater
DK3743064T3 (da) Behandling af proteinuri
TWI799655B (zh) 用後即棄式口罩
DK3430004T3 (da) Faststofformer af nilotinibsalte
DK3820849T3 (da) Phenyl/pyridyl-nh-phenyl/pyridyl-derivater til behandling af rna-virusinfektion
DK3749673T3 (da) Krystallinsk form af bictegravir-natrium
DK3532072T3 (da) Behandling af glaukom
DK3416654T3 (da) Medicinsk anvendelse af 5'-adenosindiphosphatribose (adpr)
DK3746279T3 (da) Sammenkobling af formdele
MA52297A (fr) Composé hétérocyclique